Janssen Takes A Step Closer To A Universal Flu Vaccine
This article was originally published in Scrip
Executive Summary
Scientists at Janssen (Johnson & Johnson, formerly Crucell Vaccine Institute) have found a way to induce antibodies that could lead to the development of an effective universal flu vaccine and eliminate the need for annual injections.